文献速递消化内镜消化道肿瘤与早癌

帽辅助内镜切除与内镜黏膜下剥离术在异型增生巴雷特食管中的结局比较

Comparative Outcomes of Cap Assisted Endoscopic Resection and Endoscopic Submucosal Dissection in Dysplastic Barrett's Esophagus.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-11-18

该研究基于2006年1月至2020年3月单中心前瞻性数据库,比较cEMR(456例)与ESD(81例)联合消融治疗异型增生巴雷特食管的组织学结局。2年完全缓解肠化生(CRIM)累积概率及并发症率两组相似。

核心结论

  • 异型增生或黏膜内腺癌的BE患者接受ESD后CRD率高于cEMR,但2年CRIM率与并发症率两组相似。

研究设计与样本

  • 单中心前瞻性维护数据库查询,纳入2006年1月至2020年3月接受cEMR或ESD联合消融的BE患者共537例(cEMR 456例,ESD 81例)。

主要发现

  • 并发症率两组相似。

关键数值与推荐

  • CRD定义为监测组织学无异性增生;CRIM定义为无肠化生。

临床怎么用

  • 对于异型增生或黏膜内腺癌的BE患者,ESD可能获得更高的CRD率,但CRIM率与并发症率与cEMR相似。

局限性

  • 单中心回顾性数据库分析,ESD组样本量较小(81例),可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Endoscopic resection is an important component of the endoscopic treatment of Barrett's esophagus (BE) with dysplasia and intramucosal adenocarcinoma. Endoscopic resection can be performed by cap-assisted endoscopic mucosal resection (cEMR) or endoscopic submucosal dissection (ESD). We compared the histologic outcomes of ESD vs cEMR, followed by ablation. METHODS: We queried a prospectively maintained database of all patients undergoing cEMR and ESD followed by ablation at our institution from January 2006 to March 2020 and abstracted relevant demographic and clinical data. Our primary outcomes included the rate of complete remission of dysplasia (CRD): absence of dysplasia on surveillance histology, and complete remission of intestinal metaplasia (CRIM): absence of intestinal metaplasia. Our secondary outcome included complication rates. RESULTS: We included 537 patients in the study: 456 underwent cEMR and 81 underwent ESD. The cumulative probabilities of CRD at 2 years were 75.8% and 85.6% in the cEMR and ESD groups, respectively (P < .01). Independent predictors of CRD were as follows: ESD (hazard ratio [HR], 2.38; P < .01) and shorter BE segment length (HR, 1.11; P < .01). The cumulative probabilities of CRIM at 2 years were 59.3% and 50.6% in the cEMR and ESD groups, respectively (P > .05). The only independent predictor of CRIM was a shorter BE segment (HR, 1.16; P < .01). CONCLUSIONS: BE patients with dysplasia or intramucosal adenocarcinoma undergoing ESD reach CRD at higher rates than those treated with cEMR, although CRIM rates at 2 years and complication rates were similar between the 2 groups.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Codipilly DC, Dhaliwal L, Oberoi M, et al. Comparative Outcomes of Cap Assisted Endoscopic Resection and Endoscopic Submucosal Dissection in Dysplastic Barrett's Esophagus. Clin Gastroenterol Hepatol. 2020. PMID: 33220523. doi:10.1016/j.cgh.2020.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。